ATTOVIA THERAPEUTICS, INC. enters ATTOVIA THERAPEUTICS, INC. with 548.55K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 8/4/2026ACC: 0001193125-26-333373
Officer· Chief Financial Officer
Since Aug 2026
548.55K
Baseline shares
16% direct
87.84K
Direct ownership
1 position
803.44K
Derivative underlying
3 instruments
4
Security positions
460.71K indirect
Non-Derivative Holdings4
Common Stock
IndirectShares owned245.43K
Common Stock
IndirectShares owned116.10K
Common Stock
IndirectShares owned99.18K
Common Stock
DirectShares owned87.84K
Total
87.84K direct·460.71K indirect548.55K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 245.43K | Indirect |
| Common Stock | 116.10K | Indirect |
| Common Stock | 99.18K | Indirect |
| Common Stock | 87.84K | Direct |
| Total | 548.55K | 87.84K direct·460.71K indirect |
Derivative Holdings3
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
370.29K
Shares owned
N/A
Exercise price
4.9237
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
409.71K
Shares owned
N/A
Exercise price
3.5302
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
23.44K
Shares owned
N/A
Exercise price
1.5793
Expiration
—
Exercise window
—
Total
Underlying
803.44K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 4.9237 | — | — | 370.29K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 3.5302 | — | — | 409.71K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 1.5793 | — | — | 23.44K | N/A |
| Total | 803.44K | 0.00 | ||||